Nicolas Lamblin

6PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Respiratory diseasesCardiology (incl. cardiovascular diseases)Energy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 18, 2026
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report.

|Jan 29, 2026
Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP.

Emmanuelle Berthelot, Fabrice Bauer, Charles Fauvel

|Apr 08, 2025
Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of « hasard ».

Charles Fauvel, Nicolas Lamblin

|Jul 26, 2024
Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.

Charles Fauvel, Thibaud Damy, Emmanuelle Berthelot

|Dec 22, 2023
Feasibility and prognostic significance of ventricular-arterial coupling after myocardial infarction: the RIGID-MI cohort.

Samy Aghezzaf, Augustin Coisne, Christophe Bauters

|Aug 03, 2022
Clinical significance of myocardial work parameters after acute myocardial infarction.

Augustin Coisne, Victor Fourdinier, Gilles Lemesle

Pageof 1

Frequent Collaborators

3 joint publications

Gilles Lemesle

2 joint publications

Augustin Coisne

2 joint publications

Erwan Donal

2 joint publications

Christophe Bauters